Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients

Omalizumab for Chronic Urticaria in Children Less than 12 Years of Age: A Systematic Review.

(2019) Taha Al-Shaikhly et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

High-dose omalizumab use in patients with chronic spontaneous urticaria

(2019) Mehran Alizadeh Aghdam et al.   Journal of Allergy and Clinical Immunology-In Practice

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

(2018) T. Zuberbier et al.   ALLERGY

Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study

(2018) M.N. Ghazanfar et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria

(2018) Tessa Niemeyer-van der Kolk et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Determinants of omalizumab drug survival in a long-term daily practice cohort of patients with Chronic Urticaria

(2018) Lotte. S. Spekhorst et al.   ALLERGY

Chronic urticaria in a child affected by atopic dermatitis: effective treatment with omalizumab

(2018) Lucia Leonardi et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Outcomes of using omalizumab for more than 1 year in refractory chronic urticaria

(2015) Daniel Har et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Real-life long-term omalizumab therapy in children with severe allergic asthma

(2015) Antoine Deschildre et al.   EUROPEAN RESPIRATORY JOURNAL

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study

(2015) Sarbjit S. Saini et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls

(2015) Juul M.P.A. van den Reek et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series

(2015) Elena Netchiporouk et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria

(2013) Ravi K. Viswanathan et al.   ALLERGY AND ASTHMA PROCEEDINGS

Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey

(2013) Antoine Deschildre et al.   EUROPEAN RESPIRATORY JOURNAL

Pediatric Urticaria

(2013) Teresa Tsakok et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

An algorithm for treating chronic urticaria with omalizumab: Dose interval should be individualized

(2013) Pınar Uysal et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis

(2013) Martin Metz et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

(2013) Marcus Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria

(2011) Susan D. Mathias et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

(2011) Sarbjit Saini et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma

(2010) M. Kulus et al.   CURRENT MEDICAL RESEARCH AND OPINION

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma

(2009) Bob Lanier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY